American Herbal Products Association (AHPA) > News > Latest News

AHPA Virtual Sports Nutrition Congress to identify opportunities and challenges for growing industry

Sports nutrition industry veterans will collaborate to help ensure long-term success

The American Herbal Products Association (AHPA), is excited to present the virtual Sports Nutrition Congress on Oct. 21 to deliver critical information that will help companies capitalize on opportunities, address challenges and help ensure the long-term success of the perpetually growing sport and fitness food and supplement industry.

AHPA President Michael McGuffin named to Nutritional Outlook Editorial Advisory Board

AHPA President excited to collaborate with Nutritional Outlook and help deliver trusted and timely coverage to their readers

Nutritional Outlook announced that AHPA President Michael McGuffin is one of 10 new members of the publication's editorial advisory board.

IADSA update on international supplement regulations

IADSA update on international supplement regulations

September 2020 IADSA Newsflash

In this issue of the IADSA Newsflash:  France alerts consumers about food supplements with claims of curing or preventing COVID-19; Israel notifies WTO about revised limits for polyaromatic hydrocarbons (PAHs) in food supplements; Brazil's new resolution mandating a label when food supplements have a new formulation; Ecuador issues rules for cannabis (hemp seed) supplements; and Peru has established a basic regulation governing health claims applicable to supplement products.

Supplement and Hemp Industry Associations Applaud Bipartisan Legislation to Regulate Hemp-Derived CBD

September 4, 2020: Bill directs FDA to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD

the four leading dietary supplement industry associations applaud Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD and assure consumer protection.

September 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The September 2020 AHPA Report includes: Inaugural Sports Nutrition Congress; Hemp-CBD Supplement Congress now on-demand; 9th Annual Botanical Congress; AHPA seeks more time for small firms to comply with new labeling rules; Statement on oleandrin; Senator hoping for sensible guidance on CBD; Hemp-CBD market growth; and more.

AHPA updates online Botanical Safety Handbook

AHPA updates online Botanical Safety Handbook

New safety information added to 11 botanicals

AHPA continues to expand and update the online Botanical Safety Handbook 2nd ed. to provide the herbal industry with comprehensive safety information on over 500 species of herbs from clinical trials, pharmacological and toxicological studies, medical case reports, and historical texts. New safety information has been added to entries on 11 botanicals.

AHPA joins request to give small firms more time to meet new FDA food labeling rules

AHPA urges FDA to extend enforcement discretion to small firms

AHPA joined 16 other trade associations in a Aug. 21 letter to the Food and Drug Administration (FDA) to request more time for small businesses to understand and comply with the Agency’s new, wide-ranging nutrition labeling regulations.

AHPA Statement on oleandrin and Nerium oleander

AHPA strongly discourages sales or marketing of dietary supplements that contain any part of the oleander plant

Over the last few days, the potential use of oleandrin for treatment of COVID-19 has received significant media attention. The American Herbal Products Association (AHPA) strongly discourages sales or marketing of dietary supplements that contain any part of the oleander plant (Nerium oleander) or its constituent, oleandrin. AHPA also urges physical and online retailers to refrain from offering any such products for sale, and AHPA cautions consumers to avoid oral consumption of oleander or oleandrin.

August 2020 AHPA Report

AHPA Members, Log in to access the AHPA Report

The August 2020 AHPA Report includes: FDA announces resumption of domestic inspections; Daily consumption of certain cranberry products reduces risk of recurrent UTIs; Final guidance on BE labeling; Virtual Hemp-CBD Supplement Congress on Aug. 27; and more.

IADSA update on international supplement regulations

IADSA update on international supplement regulations

July 2020 IADSA Newsflash

This issue of the IADSA Newsflash covers Australia TGA reclassifies certain sports supplements to be regulated as medicines, South Africa down scheduled CBD to a category of complementary medicine, Korea has updated its functional food code to include ginseng as helpful to bone health and the European Commission (EC) acknowledges the potential to consider traditional use of botanicals in the efficacy assessment of health claims when traditional medicine products exist for botanicals used in foods.

RSS
12345678910 Last

2021 Annual Fund Sponsors

    

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.